ClinicalTrials.govpublic full text
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
multiple myeloma, antigens, cd40, antibody, monoclonal, blood coagulation disorders, hematologic diseases, hemorrhagic disorders, hemostatic disorders, immunoproliferative disorders, lymphoproliferative disorders, paraproteinemias, vascular diseases, antibody-dependent cell cytotoxicity
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802146
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.